This HTML5 document contains 165 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q35208656
rdf:type
wikibase:Item
schema:description
vetenskaplig artikel artículo científico publicado en 2012 bilimsel makale article científic articolo scientifico 2012年論文 scienca artikolo مقالة علمية vitskapeleg artikkel article scientifique (publié 2012) wetenschappelijk artikel 2012年论文 bài báo khoa học научни чланак tieteellinen artikkeli мақолаи илмӣ naučni članak 2012年论文 научна статия artikulong pang-agham научни чланак 2012年論文 artículu científicu espublizáu en 2012 artigo científico (publicado na 2012) 2012 թուականի Մարտին հրատարակուած գիտական յօդուած 2012년 논문 2012年の論文 wissenschaftlicher Artikel tudományos cikk ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ مقالهٔ علمی 2012年论文 articol științific наукова стаття, опублікована в березні 2012 мақолаи илмӣ 2012年論文 scientific article artikull shkencor מאמר מדעי vědecký článek artykuł naukowy სამეცნიერო სტატია 2012年論文 επιστημονικό άρθρο บทความทางวิทยาศาสตร์ 2012 թվականի մարտին հրատարակված գիտական հոդված 2012年论文 artigo científico mokslinis straipsnis vedecký článok 2012 nî lūn-bûn videnskabelig artikel (udgivet 2012) 2012年论文 2012年论文 научная статья vitenskapelig artikkel سائنسی مضمون article scientific 2012年論文 artigo científico (publicado na 2012) teaduslik artikkel
p:P577
wds:Q35208656-0D3B8F1D-E258-4FA8-AF3A-204D5C0010BF
wdt:P577
2012-03-22T00:00:00Z
p:P407
wds:Q35208656-9618EC4D-4873-4E02-8CC4-AE6815BE6528
wdt:P407
wd:Q1860
p:P2860
wds:Q35208656-0375A75F-BA45-4DC8-A100-0B637C9BF28D wds:Q35208656-04054AF6-4EE2-4DE8-B1C2-E3CB0FFFBAC6 wds:Q35208656-05EBCE08-97A0-4F00-9C1A-4CA0929EA38F wds:Q35208656-09E171FD-65A1-4F97-B7C1-C15D82225CDC wds:Q35208656-2A85640F-DD07-4291-B5C1-55A3964EBE67 wds:Q35208656-2D8E71FF-E394-462D-A368-4C06F8B098AA wds:Q35208656-39373E40-7ECC-44D1-BA25-F30FCB44CDBB wds:Q35208656-3C7927F3-B7A3-4AE9-A98B-B3F1146EE1AA wds:Q35208656-527D10EE-6C26-44A2-939D-534F42895CE6 wds:Q35208656-538889BB-CACF-4654-BF0F-E2A0D8AD3301 wds:Q35208656-56378821-035F-4246-ADAC-31F9EE54D8A4 wds:Q35208656-66C760DD-814F-4D32-BB58-DC3838C7377E wds:Q35208656-6DF810C5-26D4-4161-A0D2-FD5BF2AB48BE wds:Q35208656-795F4FE2-DE76-4232-A7B7-85CB8E8AA412 wds:Q35208656-83BC9925-2F9B-4CC2-94B5-941EE9635486 wds:Q35208656-92E9F1CA-00C4-46E5-B251-4DABAEC5C5FE wds:Q35208656-95028CE3-743D-4488-A1FF-38E2A1420D1A wds:Q35208656-996B0306-6023-4794-9A7C-CA8ED9ECB4B6 wds:Q35208656-9F4CEABF-75AE-41AF-9EA0-E167CC36483B wds:Q35208656-A0805B70-E1FE-4D62-8C69-F8AA1AF13AFA wds:Q35208656-AB5A8B6A-0A33-4712-8139-039F49AD1F30 wds:Q35208656-B240A2FF-A044-4047-8570-08AEEA996B5A wds:Q35208656-CDB6955E-7367-454C-B84F-49BB3CBF6519
wdt:P2860
wd:Q38458439 wd:Q37230030 wd:Q73947549 wd:Q77593189 wd:Q30194623 wd:Q77827953 wd:Q39480713 wd:Q80600342 wd:Q24614033 wd:Q80042813 wd:Q28646514 wd:Q44558334 wd:Q44509580 wd:Q37717830 wd:Q44106095 wd:Q46603388 wd:Q44781757 wd:Q42855032 wd:Q43545482 wd:Q74182206 wd:Q28183827 wd:Q74447044 wd:Q24568164
p:P2093
wds:Q35208656-07339E83-1AFC-48C4-A77F-49C1E6A9D3F9 wds:Q35208656-E53F47A4-2093-4714-840E-3CF5B08544B3 wds:Q35208656-C02DEB39-8B86-45B9-90AA-EE6B2A37D1BF wds:Q35208656-AC12F698-7A4C-42FB-A847-B1196F29A63B wds:Q35208656-F9D74B17-3075-4F03-BA31-846568B1C58A wds:Q35208656-74ABF20A-8ABA-42DA-A733-836E5A647DA7 wds:Q35208656-6F47C86C-D7CF-4A57-A01C-16FE8BF51037 wds:Q35208656-6EDB47F8-6D3B-45B6-85AE-C10DB8DB374B wds:Q35208656-937B9095-F4B3-43ED-98D4-369CD5414EAD
wdt:P2093
Heather A Lankes William E Brady Michael A Gold Joseph L Kelley Marta A Crispens Koen De Geest Stephen B Howell Kimberly E Resnick Peter G Rose
rdfs:label
A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study
skos:prefLabel
A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study
schema:name
A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study
p:P1476
wds:Q35208656-C38E4429-4EB0-4EBA-8A7D-4CB3CD83CCA8
wdt:P1476
A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study
p:P304
wds:Q35208656-3F51F32F-965D-4750-89C9-1DE314BACC11
wdt:P304
635-639
p:P31
wds:Q35208656-23BA75D7-C640-49B4-8959-61753A7A4EF5
wdt:P31
wd:Q13442814
p:P921
wds:Q35208656-3D78F8F7-0CAB-48F9-A1A0-246131698FA1 wds:Q35208656-2A521484-53F0-4A5A-ADEC-C59C449DFCA3 wds:Q35208656-AA6976DD-D87A-4488-B611-FB350EA36B0E
wdt:P921
wd:Q1233836 wd:Q5625186 wd:Q1816041
p:P698
wds:Q35208656-FF62B064-BA97-4104-842A-0E86CA9338E5
wdtn:P698
n12:22446624
wdt:P698
22446624
p:P1433
wds:Q35208656-1378976E-60C6-4ECF-9CA0-D7BB5BD4EC0A
wdt:P1433
wd:Q5625182
p:P433
wds:Q35208656-2495DF01-283D-4D6A-B0AA-621E6CB9391E
p:P478
wds:Q35208656-2FC283E5-45B1-4E01-A458-CA45D578CA59
wdt:P433
3
wdt:P478
125
p:P356
wds:Q35208656-1741741D-F61B-416C-9004-D1980F308733
wdtn:P356
n11:J.YGYNO.2012.03.023
wdt:P356
10.1016/J.YGYNO.2012.03.023
p:P932
wds:Q35208656-7467480D-D12E-40FC-838C-A8A3FF77F706
wdt:P932
4370623